<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="896">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01905254</url>
  </required_header>
  <id_info>
    <org_study_id>UKE IRB 2742</org_study_id>
    <nct_id>NCT01905254</nct_id>
  </id_info>
  <brief_title>Transient Elastography in Autoimmune Hepatitis</brief_title>
  <official_title>Prospective Comparison of Transient Elastography and Mini-laparoscopic Guided Liver Biopsy in Autoimmune Hepatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent, research has focused on the evaluation of non-invasive methods for the assessment of
      liver fibrosis in patients with chronic liver disease. Among these methods, transient
      elastography is the most promising. The method has been investigated mainly in patients with
      viral hepatitis. Several studies have shown, that the optimal cut-off value of TE for
      detection of liver cirrhosis by transient elastography is highly dependent on the aetiology
      of the underlying liver disease. Only a few studies have evaluated the value of transient
      elastography for patients with autoimmune liver disease and here primarily patients with PBC
      and PSC. For patients with autoimmune hepatitis the data is limited. We prospectively
      investigated the diagnostic accuracy of TE in autoimmune hepatitis compared to liver
      histology with and without inclusion of the macroscopic appearance using mini-laparoscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the current study was to assess the diagnostic performance of transient
      elastography for the determination of cirrhosis in patients with autoimmune hepatitis
      compared to the diagnosis of cirrhosis made on Laparoscopic guided liver biopsy. Patients
      referred for liver biopsy and transient elastography with a clinical diagnosis of AIH
      followed in the liver clinic of the Department of Gastroenterology at the UKE were
      prospectively included in the study.

      Inclusion criteria were as follows: Confirmed diagnosis of AIH based on the diagnostic
      criteria revised by the International Autoimmune Hepatitis Group 2008 (20): 1. liver related
      autoantibodies, 2. hypergammaglobulinaemia, 3.typical histological findings and 4. absence
      of viral markers. Exclusion criteria were morbid obesity (BMI &gt; 40), ascites, ileus or
      subileus, peritonitis, pregnancy, extrahepatic cholestasis and a severe inflammatory flare
      of AIH.

      Blood liver tests including gamma-globulines, IgG, IgM, liver related autoantibodies (ANA,
      AMA, LKM, SMA, SLA) and viral markers (HBsAg, Anti HBs, Anti HBc, Anti HCV, Anti HAV) were
      performed before LB.

      Each patient underwent abdominal ultrasound to exclude extrahepatic cholestasis prior to TE
      and minilaparoscopic liver biopsy. TE and minilaparoscopy were performed by physicians
      blinded to the results the other within a period of less than 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Sensitivity and Specifity of Transient Elastography in Detection of Liver Cirrhosis</measure>
    <time_frame>Transient Elastography compared to liver histology</time_frame>
    <safety_issue>No</safety_issue>
    <description>The aim of the current study was to assess the diagnostic accuracy (Sens., Spec.) of transient elastography for the determination of cirrhosis in patients with autoimmune hepatitis. TE was compared to the diagnosis of cirrhosis made on histology yielded by laparoscopic guided liver biopsy.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Transient elastography and liver biopsy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients with Autoimmune hepatitis (AIH) were investigated with Transient Elastography before liver biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transient elastography (TE)</intervention_name>
    <description>TE and minilaparoscopic guided liver biopsy were performed by physicians blinded to the results the other within a period of less than 3 months.</description>
    <arm_group_label>Transient elastography and liver biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liver biopsy</intervention_name>
    <description>Minilaparoscopic guided liver biopsy was performed within a period of 3 months of Transient Elastography</description>
    <arm_group_label>Transient elastography and liver biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Confirmed diagnosis of AIH based on the diagnostic criteria revised by the International
        Autoimmune Hepatitis Group 2008 (20):

          1. liver related autoantibodies,

          2. hypergammaglobulinaemia,

          3. typical histological findings and

          4. absence of viral markers.

        Exclusion Criteria:

          -  morbid obesity (BMI &gt; 40),

          -  ascites, ileus or subileus,

          -  peritonitis,

          -  pregnancy,

          -  extrahepatic cholestasis and

          -  a severe inflammatory flare of AIH.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrike W Denzer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ansgar W Lohse, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept of Gastroenterology and Hepatology, University Medical Center Hamburg Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <lastchanged_date>May 4, 2015</lastchanged_date>
  <firstreceived_date>July 1, 2013</firstreceived_date>
  <firstreceived_results_date>December 7, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>PD Dr. med. Ulrike Denzer</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <keyword>Transient elastography</keyword>
  <keyword>mini-laparoscopy</keyword>
  <keyword>liver biopsy</keyword>
  <keyword>liver cirrhosis</keyword>
  <keyword>autoimmune hepatitis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hepatitis, Autoimmune</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Thirty-nine patients with AIH were eligible during the study period. Five patients were excluded: 4 patients due to ineffective or incomplete (&lt;60% success rate) liver stiffness measurement, and 1 patient with a severe acute flare of AIH with markedly elevated liver enzymes.&quot;</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Transient Elastography and Liver Biopsy</title>
          <description>Transient elastography was performed by two experienced investigators using a FibroScan (EchoSens, Paris, France), the median value of liver stiffness measurements was recorded in kilopascals (kPa).
Liver biopsy was carried out within 3 months of TE. Liver biopsies from the right and left lobe were obtained under laparoscopic control using the Tru-cut 16 GAUGE needle (Bard monopty; Bard biopsy systems, Tempe, USA).
Data analysis was performed on the remaining 34 patients (female: 28 (82%); male: 6 (18 %).
Indications for liver biopsy and Transient elastography were: 19 patients for follow-up of AIH while receiving immunosuppression and 15 patients for staging and grading of AIH before starting with an immunosuppressive therapy in.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Data analysis was performed on 34 patients (female: 28 (82%); male: 6 (18 %). Indications for liver biopsy and Transient elastography were: 19 patients for follow-up of AIH while receiving immunosuppression and 15 patients for staging and grading of AIH before starting with an immunosuppressive therapy in.</population>
      <group_list>
        <group group_id="B1">
          <title>Single Arm Study</title>
          <description>Alle patients received a liver biopsy and Transient elastopgrapy for follow-up of Autoimmune Hepatitis or staging and grading of Autoimmune hepatitis.</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="53" lower_limit="21" upper_limit="74"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>American Indian or Alaska Native</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Asian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Native Hawaiian or Other Pacific Islander</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black or African American</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>More than one race</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Germany</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity and Specifity of Transient Elastography in Detection of Liver Cirrhosis</title>
        <description>The aim of the current study was to assess the diagnostic accuracy (Sens., Spec.) of transient elastography for the determination of cirrhosis in patients with autoimmune hepatitis. TE was compared to the diagnosis of cirrhosis made on histology yielded by laparoscopic guided liver biopsy.</description>
        <time_frame>Transient Elastography compared to liver histology</time_frame>
        <safety_issue>No</safety_issue>
        <population>Sensitivity, specifity; Positive and negative predictive value of TE for diagnosis of cirrhosis was analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Transient Elastography in Autoimmune Hepatitis</title>
            <description>Liver stiffness (kPa) was correlated to histologic staging of liver cirrhosis</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="34"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Sensitivity and Specifity of Transient Elastography in Detection of Liver Cirrhosis</title>
            <description>The aim of the current study was to assess the diagnostic accuracy (Sens., Spec.) of transient elastography for the determination of cirrhosis in patients with autoimmune hepatitis. TE was compared to the diagnosis of cirrhosis made on histology yielded by laparoscopic guided liver biopsy.</description>
            <units>Probability</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Sensitivity of TE for diagnosis cirrhosis</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.83"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Specifity of TE for diagnosis cirrhosis</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.00"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Positive predictive value of TE for cirrhosis</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.00"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Negative predictive value of TE for cirrhosis</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.97"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>TE in Autoimmune Hepatitis</title>
          <description>Alle patients received a liver biopsy and Transient elastopgrapy for follow-up of Autoimmune Hepatitis or staging and grading of Autoimmune hepatitis.
There were no adverse events.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pain after liver biopsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding after liver biopsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>PD Dr. Ulrike Denzer</name_or_title>
      <organization>Universitiy Clinic Hamburg eppendorf</organization>
      <phone>040741055380</phone>
      <email>u.denzer@uke.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
